Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 8
1987 5
1988 7
1989 14
1990 8
1991 7
1992 7
1993 10
1994 16
1995 8
1996 9
1997 8
1998 13
1999 15
2000 16
2001 17
2002 11
2003 12
2004 14
2005 12
2006 12
2007 13
2008 11
2009 16
2010 24
2011 22
2012 26
2013 22
2014 16
2015 20
2016 19
2017 12
2018 19
2019 19
2020 24
2021 24
2022 27
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

512 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. Among authors: rascol o. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
LRRK2 in Parkinson disease: challenges of clinical trials.
Tolosa E, Vila M, Klein C, Rascol O. Tolosa E, et al. Among authors: rascol o. Nat Rev Neurol. 2020 Feb;16(2):97-107. doi: 10.1038/s41582-019-0301-2. Epub 2020 Jan 24. Nat Rev Neurol. 2020. PMID: 31980808 Review.
Trial of Cinpanemab in Early Parkinson's Disease.
Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T; SPARK Investigators. Lang AE, et al. Among authors: rascol o. N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395. N Engl J Med. 2022. PMID: 35921450 Clinical Trial.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force. Goetz CG, et al. Among authors: rascol o. Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340. Mov Disord. 2008. PMID: 19025984
Multiple System Atrophy: Recent Developments and Future Perspectives.
Meissner WG, Fernagut PO, Dehay B, Péran P, Traon AP, Foubert-Samier A, Lopez Cuina M, Bezard E, Tison F, Rascol O. Meissner WG, et al. Among authors: rascol o. Mov Disord. 2019 Nov;34(11):1629-1642. doi: 10.1002/mds.27894. Epub 2019 Nov 6. Mov Disord. 2019. PMID: 31692132 Review.
COMT Inhibitors in the Management of Parkinson's Disease.
Fabbri M, Ferreira JJ, Rascol O. Fabbri M, et al. Among authors: rascol o. CNS Drugs. 2022 Mar;36(3):261-282. doi: 10.1007/s40263-021-00888-9. Epub 2022 Feb 25. CNS Drugs. 2022. PMID: 35217995 Review.
Off-time Treatment Options for Parkinson's Disease.
Fabbri M, Barbosa R, Rascol O. Fabbri M, et al. Among authors: rascol o. Neurol Ther. 2023 Apr;12(2):391-424. doi: 10.1007/s40120-022-00435-8. Epub 2023 Jan 12. Neurol Ther. 2023. PMID: 36633762 Free PMC article. Review.
512 results